Experimental validation revealed that ACADSB and ACADM decreased in patients with UC. by Hongliang Chen (538815)

Inhibition of the lysosomal protease decreased the apoptosis induced by EV71. by Xueyan Xi (5654083)

Decreased podocyte adhesion due to injury is partially recovered by EV. by Stefanie Jeruschke (281665)

Decreased DG GCL volume of postnatal CRAF ko mice. by Verena Pfeiffer (158248)

dnMAML decreases cartilage formation during fracture healing. by Michael I. Dishowitz (430286)

“…<p>(<b>A</b>) Percent of cartilage area to total callus area (CA/TA) via SafO histomorphometric analysis is decreased in dnMAML fractures at 10dpf. …”

53BP1 protein abundance decreases upon irradiation. by Yiheng Hu (648082)

Viral replication in obese mice results in decreased genetic diversity. by James Weger-Lucarelli (603766)

Irradiation decreased the number of DCX⁺ cells in the OB. by Françoise Lazarini (259707)

Decreased CoREST1 expression reduced tumor angiogenesis. by Sohini Mazumdar (707540)

ROCK inhibition decreases the motility of MHCC97H cells. by Ji-Gang Zhang (278184)

“…Original magnification was 100×, scale bars represent 125 µm. (<b>C</b>) Y27632 inhibition decreased invasiveness. …”

CCR2 depletion decreases lipid accumulation in the liver and WAT. by Seung Joo Lee (1766020)

“…<p>(a) To analyze lipid accumulation in tissues, H&E staining was performed. …”

Brivanib decreases the transcription of growth factors and their receptors in carbon tetrachloride. by Ikuo Nakamura (548298)

“…<p>Hepatic levels of growth factors and growth factor receptor mRNA were measured by real time PCR in sham and CCl₄ mice treated with no brivanib or with brivanib 25 mg/kg, 50 mg/kg, or 100 mg/kg. In all of the sham experiments, higher concentrations of brivanib decreased the mRNA levels of the growth factors and their receptors. …”

Decreased HRG turnover with anti-CSF1 antibody treatment. by Sònia Tugues (632541)

Lack of p23 results in decreased epidermal thickness, delayed differentiation and increased rates of proliferation and apoptosis in E18.5 skin. by Marta Madon-Simon (527400)

“…(<b>b</b>) Quantitation of epidermal thickness and (<b>c</b>) number of hair follicle per 100 μm basal membrane (BM) in <i>p23</i>^<i>-/-</i> and wild-type E18.5 skin sections; significant decrease of epidermal thickness (*** p<0.001) and hair follicle numbers (** p<0.01) in <i>p23</i>^<i>-/-</i> skin (n: WT = 4, <i>p23</i>^<i>-/-</i> = 3). …”

Histamine treatment dose-dependently decreases sleep duration and it decreases sleep duration of <i>ort</i> mutant but not of <i>hisCl</i>1 mutants. by Yangkyun Oh (430059)

Decrease of junctional zone area in low protein placentas at E10.5, E17.5 and E18.5. by Paula N. Gonzalez (372538)

Colony survival is decreased in UUC-enriched deletion mutants after exposure to oxidative stress-inducing agents. by Lauren Endres (765718)

“…The inset shows the magnitude of the decrease in survival (i.e., percent survival untreated minus treated conditions for individual strains). …”

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the tension of co... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the tension of co... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the amplitude of... by Barbara Jana (9110179)